Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

BEDROC study investigators, Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H Young, Peter Surman

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science